Hypoxia-inducible APCDD1L-AS1 promotes osimertinib resistance by stabilising DLST to drive tricarboxylic acid cycle in lung adenocarcinoma

Quanli Zhang(China Pharmaceutical University), Minghui Li(Jiangsu Cancer Hospital)
Journal of Experimental & Clinical Cancer Research
July 9, 2025
Cited by 3


Related Papers